Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David G. Addiss is active.

Publication


Featured researches published by David G. Addiss.


Emerging Infectious Diseases | 2003

Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil.

Lílian Maria Garcia Bahia-Oliveira; Jeffrey L. Jones; Juliana Azevedo-Silva; Cristiane C.F. Alves; Fernando Oréfice; David G. Addiss

In Campos dos Goytacazes, northern Rio de Janeiro state, Brazil, reports of uveitis consistent with toxoplasmosis led to a survey of the prevalence and risk factors for Toxoplasma gondii infection in 1997–1999. The survey population was selected randomly from schools, randomly chosen communities, and an army battalion. Serum samples from 1,436 persons were tested. With results adjusted for age, 84% of the population in the lower socioeconomic group was seropositive, compared with 62% and 23% of the middle and upper socioeconomic groups, respectively (p<0.001). When multivariate analysis was performed, drinking unfiltered water was found to increase the risk of seropositivity for the lower socioeconomic (odds ratio [OR]: 3.0, 95% confidence interval [CI] 1.3 to 6.9) and middle socioeconomic (OR: 1.7, 95% CI 1.2 to 2.3) populations. We also found a high T. gondii seroprevalence in this Brazilian community. Drinking unfiltered water increased the risk of T. gondii seropositivity, indicating the potential importance of oocyst transmission in water in this region.


Emerging Infectious Diseases | 2003

Cost of Illness in the 1993 Waterborne Cryptosporidium Outbreak, Milwaukee, Wisconsin

Phaedra S. Corso; Michael H. Kramer; Kathleen A. Blair; David G. Addiss; Jeffrey P. Davis; Anne C. Haddix

To assess the total medical costs and productivity losses associated with the 1993 waterborne outbreak of cryptosporidiosis in Milwaukee, Wisconsin, including the average cost per person with mild, moderate, and severe illness, we conducted a retrospective cost-of-illness analysis using data from 11 hospitals in the greater Milwaukee area and epidemiologic data collected during the outbreak. The total cost of outbreak-associated illness was


Filaria Journal | 2007

Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature

David G. Addiss; Molly A Brady

96.2 million:


Sexually Transmitted Diseases | 1993

Decreased Prevalence of Chlamydia trachomatis Infection Associated With a Selective Screening Program in Family Planning Clinics in Wisconsin

David G. Addiss; Michael L. Vaughn; Deborah Ludka; John Pfister; Jeffrey P. Davis

31.7 million in medical costs and


American Journal of Obstetrics and Gynecology | 1994

Risk factors for recurrent Chlamydia trachomatis infections in women

Susan D. Hillis; Allyn Nakashima; Polly A. Marchbanks; David G. Addiss; Jeffrey P. Davis

64.6 million in productivity losses. The average total costs for persons with mild, moderate, and severe illness were


The Lancet | 1996

Schistosomiasis in Lake Malawi

Martin S. Cetron; Lester Chitsulo; James J. Sullivan; Joy B. Pilcher; Marianna Wilson; John Noh; Victor C. W. Tsang; Allen W. Hightower; David G. Addiss

116,


The Lancet | 1997

Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children.

David G. Addiss; Michael J. Beach; Thomas G Streit; Suzanne M. Lutwick; Fredrick H LeConte; Jack Guy Lafontant; Allen W. Hightower; Patrick J. Lammie

475, and


PLOS Neglected Tropical Diseases | 2013

Integration of Water, Sanitation, and Hygiene for the Prevention and Control of Neglected Tropical Diseases: A Rationale for Inter-Sectoral Collaboration

Matthew C. Freeman; Stephanie Ogden; Julie Jacobson; Daniel Abbott; David G. Addiss; Asrat G. Amnie; Colin Beckwith; Sandy Cairncross; Rafael Callejas; Jack M. Colford; Paul M. Emerson; Alan Fenwick; Rebecca Fishman; Kerry Gallo; Jack E. T. Grimes; Gagik Karapetyan; Brooks Keene; Patrick J. Lammie; Chad MacArthur; Peter Lochery; Helen Petach; Jennifer Platt; Sarina Prabasi; Jan Willem Rosenboom; Sharon L. Roy; Darren Saywell; Lisa Schechtman; Anupama Tantri; Yael Velleman; Juerg Utzinger

7,808, respectively. The potentially high cost of waterborne disease outbreaks should be considered in economic decisions regarding the safety of public drinking water supplies.


Transactions of The Royal Society of Tropical Medicine and Hygiene | 1996

Occurrence of living adult Wuchereria bancrofti in the scrotal area of men with microfilaraemia

Joaqim Norões; David G. Addiss; Fernando Amaral; Amaury Coutinho; Zulma Medeiros; Gerusa Dreyer

The Global Programme to Eliminate Lymphatic Filariasis (GPELF) has two major goals: to interrupt transmission of the parasite and to provide care for those who suffer the devastating clinical manifestations of the disease (morbidity control). This latter goal addresses three filariasis-related conditions: acute inflammatory episodes; lymphoedema; and hydrocele. Research during the last decade has confirmed the importance of bacteria as a cause of acute inflammatory episodes in filariasis-endemic areas, known as acute dermatolymphangioadenitis (ADLA). Current lymphoedema management strategies are based on the central role of ADLA as a trigger for lymphoedema progression. Simple intervention packages are in use that have resulted in dramatic reductions in ADLA rates, a lower prevalence of chronic inflammatory cells in the dermis and subdermis, and improvement in quality of life. During the past decade, the socioeconomic impact of ADLA and lymphoedema in filariasis-endemic areas has received increasing attention. Numerous operational research questions remain to be answered regarding how best to optimize, scale up, monitor, and evaluate lymphoedema management programmes. Of the clinical manifestations targeted by the GPELF, hydrocele has been the focus of the least attention. Basic information is lacking on the effectiveness and complications of hydrocele surgery and risk of post-operative hydrocele recurrence in filariasis-endemic areas. Data on the impact of mass administration of antifilarial drugs on filarial morbidity are inconsistent. Several studies report reductions in acute inflammatory episodes, lymphoedema, and/or hydrocele following mass drug administration, but other studies report no such association. Assessing the public health impact of mass treatment with antifilarial drugs is important for programme advocacy and morbidity control strategies. Thus, although our knowledge of filariasis-related morbidity and its treatment has expanded in recent years, much work remains to be done to address the needs of more than 40 million persons who suffer worldwide from these conditions.


The Journal of Urology | 1996

Ultrasonigraphic Evidence of Abnormal Lymphatic Vessels in Young Men with Adult Wuchereria Bancrofti Infection in the Scrotal Area

Joaquim Noroes; David G. Addiss; Abiel Santos; Zulma Mereidos; Amaury Coutinho; Gerusa Dreyer

The effectiveness of selective screening for control of Chlamydia trachomatis is unknown. In 1986, a statewide screening program began in family planning clinics in Wisconsin after the prevalence of infection among women was found to be 10.7% in four nonurban clinics and 13.7% in an urban Milwaukee clinic. In 1990, endocervical specimens were obtained from 1,757 women attending these same clinics; 5.2% of women in the non-urban clinics and 6.9% in the Milwaukee clinic tested positive for C. trachomatis. Prevalence of infection had decreased similarly (by 53% overall) in both high- and low-risk groups in all five clinics. Although reported condom use increased from 16% to 31%, most other demographic and behavioral risk factors for infection did not significantly change; in contrast, the prevalence of clinical signs of infection decreased. The percentage of infections identified by selective screening criteria decreased from 77% to 55%. Selective screening and attendant activities, as well as an increase in condom use, were associated with a decrease in prevalence of C. trachomatis infection in this population.

Collaboration


Dive into the David G. Addiss's collaboration.

Top Co-Authors

Avatar

Patrick J. Lammie

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jeffrey P. Davis

Children's Hospital of Wisconsin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael J. Beach

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Joaquim Norões

Federal University of Pernambuco

View shared research outputs
Top Co-Authors

Avatar

Dennis D. Juranek

United States Department of Health and Human Services

View shared research outputs
Top Co-Authors

Avatar

Jacquelin M. Roberts

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge